Healthy men test new enbrel copycat in drug comparison study
NCT ID NCT06392074
First seen Nov 01, 2025 · Last updated Apr 30, 2026 · Updated 24 times
Summary
This study tested a new biosimilar drug called MB04 against two versions of Enbrel (EU and US) in 141 healthy men. Researchers measured how much drug stayed in the blood and checked for side effects and immune reactions. The goal was to see if MB04 works similarly to Enbrel, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
ICON Clinical Research Unit
Groningen, Provincie Groningen, 9728 NZ, Netherlands
Conditions
Explore the condition pages connected to this study.